|
Originally published In Press as doi:10.1074/jbc.M609655200 on December 5, 2006
J. Biol. Chem., Vol. 282, Issue 5, 3014-3026, February 2, 2007
Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells*
Souvik Chattopadhyay 1,
Erin Tracy 1,
Ping Liang ,
Olivier Robledo 2,
Stefan Rose-John¶, and
Heinz Baumann 3
From the
Departments of Molecular and Cellular Biology and Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263 and the ¶Department of Biochemistry, Christian-Albrechts-Universität zu Kiel, D-24098 Kiel, Germany
Lung epithelial cells are primary targets of oncostatin M (OSM) and, to a lower degree, of interleukin (IL)-6 and IL-31, all members of the IL-6 cytokine family. The OSM receptor (OSMR) signals through activation of STAT and mitogen-activated protein kinase pathways to induce genes encoding differentiated cell functions, reduce cell-cell interaction, and suppress cell proliferation. IL-31 functions through the heteromeric IL-31 receptor, which shares with OSMR the OSMR subunit, but does not engage gp130, the common subunit of all other IL-6 cytokine receptors. Because the response of epithelial cells to IL-31 is unknown, the action of IL-31 was characterized in the human alveolar epithelial cell line A549 in which the expression of the ligand-binding IL-31R subunit was increased. IL-31 initiated signaling that differed from other IL-6 cytokines by the particularly strong recruitment of the STAT3, ERK, JNK, and Akt pathways. IL-31 was highly effective in suppressing proliferation by altering expression of cell cycle proteins, including up-regulation of p27Kip1 and down-regulation of cyclin B1, CDC2, CDK6, MCM4, and retinoblastoma. A single STAT3 recruitment site (Tyr-721) in the cytoplasmic domain of IL-31R exerts a dominant function in the entire receptor complex and is critical for gene induction, morphological changes, and growth inhibition. The data suggest that inflammatory and immune reactions involving activated T-cells regulate functions of epithelial cells by IL-6 cytokines through receptor-defined signaling reactions.
Received for publication, October 13, 2006
, and in revised form, November 16, 2006.
* This work was supported by NCI Grant CA085580 from the National Institutes of Health (to H. B.), Roswell Park Center Support Grant CA16056, and a Roswell Park Alliance grant (to H. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 Present address: Centre Hospitalier de l'Université de Montréal Research Centre, Notre Dame Hospital, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada.
3 To whom correspondence should be addressed: Dept. of Molecular and Cellular Biology, Elm and Carlton St., Buffalo, NY 14263. Tel.: 716-845-4587; Fax: 716-845-5908; E-mail: heinz.baumann{at}roswellpark.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. G. Perrigoue, C. Zaph, K. Guild, Y. Du, and D. Artis
IL-31-IL-31R Interactions Limit the Magnitude of Th2 Cytokine-Dependent Immunity and Inflammation following Intestinal Helminth Infection
J. Immunol.,
May 15, 2009;
182(10):
6088 - 6094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Dolgachev, M. R. Ullenbruch, N. W. Lukacs, and S. H. Phan
Role of Stem Cell Factor and Bone Marrow-Derived Fibroblasts in Airway Remodeling
Am. J. Pathol.,
February 1, 2009;
174(2):
390 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Quinton, M. R. Jones, B. E. Robson, B. T. Simms, J. A. Whitsett, and J. P. Mizgerd
Alveolar Epithelial STAT3, IL-6 Family Cytokines, and Host Defense during Escherichia coli Pneumonia
Am. J. Respir. Cell Mol. Biol.,
June 1, 2008;
38(6):
699 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dambacher, F. Beigel, J. Seiderer, D. Haller, B. Goke, C. J Auernhammer, and S. Brand
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Gut,
September 1, 2007;
56(9):
1257 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|